Eric Powers to Immunoglobulin Fab Fragments
This is a "connection" page, showing publications Eric Powers has written about Immunoglobulin Fab Fragments.
Connection Strength
0.058
-
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. N Engl J Med. 2001 Jun 21; 344(25):1888-94.
Score: 0.046
-
Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial. Circulation. 2002 May 21; 105(20):2347-54.
Score: 0.012